Stock NBRVF NABRIVA THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Nabriva Therapeutics plc

Equities

NBRVF

IE000OZRGNV6

Delayed OTC Markets
Other stock markets
 11:34:09 2024-04-25 am EDT 		5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Nabriva Therapeutics plc 0.00% +9,900.00%
2023 Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
2023 Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Northland Capital Adjusts Nabriva Therapeutics' Price Target to $2 from $4, Keeps Outperform Rating
MT
NABRIVA THERAPEUTICS : Jefferies Starts Nabriva Therapeutics at Hold with $1.35 Price Target
MT
NABRIVA THERAPEUTICS : Northland Securities Adjusts Nabriva Therapeutics' Price Target to $6 from $9, Keeps Outperform Rating
MT
Nabriva Therapeutics plc Announces the Publication of A Study Documenting the High Rates of Macrolide-Resistant Streptococcus Pneumoniae Throughout the United States
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NBRVF Stock
  4. News Nabriva Therapeutics plc
  5. Analyst Reco.